It is worth noting that enhanced Cox2 expression potently enhances both colon cancer in humans and tumorigenesis in Apcmin/+ mice; specifically, inhibition of Cox2 expression or its enzymatic activity by nonsteroidal anti-inflammatory drugs greatly suppresses tumor development [20]. Here, PTGS2 is linked to malignant colon neoplasm.